Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases. In some patients, the disease returns or progresses within six months of the ...

A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...

Whereas most of the cells in a healthy animal’s body get along by following the same set of genetic rules, cancer cells ...

Tongue cancer (TC) cells can enter a chemo-resistant state by activating pathways related to autophagy and cholesterol synthesis, report researchers. Using a large-scale library of TC organoids they ...

A standard cardiovascular treatment is reported to disable treatment-resistant breast cancer cells by directly blocking the Mcl-1 protein SEOUL, South Korea, Jan. 7, 2026 /PRNewswire/ --A Korea ...

Pancreatic cancer research tackles treatment resistance with targeted drug delivery, immune-boosting combinations, and ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

A new drug that works by making tumors more susceptible to chemotherapy and the immune system has increased survival in those ...

About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist ...

New research shows that certain flavonols from everyday foods can shut down the body’s drug-resistance machinery, potentially paving the way for more effective treatments, but clinical hurdles remain.